Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis by Pizzolato K, Thacker D, Del Toro-Pagán NM, Amin NS, Hanna A, Turgeon J, Michaud V

Get full text

CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum by Palmer, EE, Whitton, C, Hashem, MO, Clark, RD, Ramanathan, S, Starr, LJ, Velasco, D, De Dios, JK, Singh, E, Cormier‐Daire, V, Chopra, M, Rodan, LH, Nellaker, C, Lakhani, S, Mallack, EJ, Panzer, K, Sidhu, A, Wentzensen, IM, Lacombe, D, Michaud, V, Alkuraya, FS